SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-072800
Filing Date
2022-06-21
Accepted
2022-06-21 10:04:09
Documents
1
Group Members
FAIRMOUNT HEALTHCARE FUND GP LLCFAIRMOUNT HEALTHCARE FUND II GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2218841d2_sc13da.htm SC 13D/A 76294
  Complete submission text file 0001104659-22-072800.txt   78117
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Subject) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90431 | Film No.: 221026420
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103 267-760-4066
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

IRS No.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A